Join Now

Category Archives: Press Releases

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021

By Press Release | Published August 5, 2021

The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on so-called nonessential medical procedures. Therefore, UTMD management reports quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Company’s stated objective in 2021 has been to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page. 

Also posted in BioUtah News | | Tagged , | Leave a comment

CenExel Clinical Research Acquires ForCare Clinical Research

By Press Release | Published August 5, 2021

CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience. CenExel FCR conducts Phase I through Phase IV studies in both chronic and acute conditions, primarily in Dermatology

Also posted in BioUtah News | | Tagged , | Leave a comment

BIOMERICS ANNOUNCES ACQUISITION OF BERG MANUFACTURING INC. & KNIGHT MACHINING LLC.

By Press Release | Published August 5, 2021

Biomerics LLC, a leading mid-market contract manufacturer for the interventional medical device market, announced it has acquired a majority interest in Berg Manufacturing Inc. Berg Manufacturing, based in Santa Clara, California, is an industry leader in Swiss micromachining for the advanced robotic surgery, endoscope, and interventional catheter markets.

Also posted in BioUtah News | | Tagged , , | Leave a comment

Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries

By Press Release | Published August 3, 2021

Advancing its mission to expand access to genetic testing, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched a new version of its market-leading MyRisk Hereditary Cancer Test. For the first time, women of all ancestries can now receive a personalized polygenic breast cancer risk assessment together with the market’s most accurate hereditary cancer test.

Also posted in BioUtah News | | Tagged | Leave a comment

BioUtah Statement on Launch of Altitude Lab’s Investor Coalition to Fund and Mentor Utah’s Life Sciences Startups

By Lori Ross | Published June 9, 2021

Salt Lake City – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences startups in Utah. BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences […]

| Leave a comment

BioUtah Statement on House Democrat Leaders Drug Pricing Legislation

By Lori Ross | Published April 23, 2021

Salt Lake City, Utah (April 22, 2021) – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement after House Democrat leaders released their drug pricing proposal, H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, based upon similar legislation introduced in the 116th Congress. “Utah has a long and proud history of […]

Also posted in BioUtah News, Policy News | | Leave a comment

Utah’s Recursion Goes Public – Announces Pricing of IPO

By Denise Bell | Published April 16, 2021

Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion is offering 24,242,424 shares of its Class A common stock. The gross proceeds from the offering are expected to be $436.4 million. The shares are expected to […]

Also posted in BioUtah News, Industry News, Utah's Life Sciences Companies | | Leave a comment

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

By Denise Bell | Published March 1, 2021

Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions […]

Also posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

By Denise Bell | Published December 4, 2020

Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test. Dwight Egan, CEO of Co-Diagnostics, said “tests built on […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections

By Denise Bell | Published October 16, 2020

Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]

Also posted in BioUtah News, COVID-19 Updates, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

A Special Thanks To Our Elite Members